Trial Profile
An Exploratory Pharmacogenomic Study of Neoadjuvant Cetuximab Followed by Cisplatin, Radiotherapy, and Cetuximab in Women With Newly Diagnosed Locally Advanced or Metastatic Cervical Carcinoma
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 06 Jul 2022
Price :
$35
*
At a glance
- Drugs Cetuximab (Primary) ; Cisplatin
- Indications Carcinoma; Cervical cancer
- Focus Therapeutic Use
- 01 Jul 2022 Results published in the American Journal of Clinical Oncology
- 27 May 2011 Planned end date changed from 1 Feb 2011 to 1 Feb 2012 as reported by ClinicalTrials.gov.
- 26 May 2009 Additional lead trial investigator Linda R. Duska identified as reported by ClinicalTrials.gov.